-
US-China Trade Tensions Pose Risk To Merit Medical's $150 Million Revenue From China
Friday, April 11, 2025 - 2:47pm | 516Read More...Merit Medical Systems Inc. (NASDAQ:MMSI) is scheduled to release its first quarter 2025 adjusted EPS of 75 cents and sales of $352.82 million, as per data on Benzinga Pro. Merit develops, manufactures and distributes proprietary medical devices used in interventional, diagnostic and therapeutic...
-
Barrington Research: With SEC Litigation Settled, Opko Health Should Outperform
Wednesday, January 9, 2019 - 11:22am | 380Read More...Opko Health Inc. (NASDAQ: OPK) lost around 57 percent over the span of a few months after the SEC named the company as a defendant in a lawsuit alleging a "pump-and-dump" stock trading by CEO and Chairman Dr. Phil Frost. The conclusion of the litigation — which ended with the...
-
Anika Therapeutics Shares Stunted By Increased Investment, Barrington Says In Downgrade
Friday, February 23, 2018 - 11:11am | 334Read More...Anika Therapeutics Inc (NASDAQ: ANIK)’s stock fell 3.4 percent Thursday after management reported a marginal top-line miss with mixed segment performances. Shares continued to fall Friday on analyst criticism. The Rating Barrington Research analyst Michael Petusky downgraded Anika from...
-
Analyst: Don't Expect Anika's Latest FDA Cleared Treatment To Impact 2018
Thursday, December 28, 2017 - 12:38pm | 340Read More...Anika Therapeutics Inc (NASDAQ: ANIK) announced Wednesday it has received clearance from the U.S. Food and Drug Administration for its HA-based bone void filler, which is used to fill bone voids or defects of the skeletal system. The Analyst Barrington Research's Michael Petusky maintains an...
-
Barrington Maintains Outperform Rating On Healthways Ahead Of Q3 Earnings
Thursday, October 13, 2016 - 11:03am | 347Read More...Barrington Research maintains an Outperform rating on Healthways, Inc. (NASDAQ: HWAY) ahead of its third-quarter results on November 1 and following the closure of the unprofitable total population health solutions business. The brokerage expects adjusted EPS of $0.52 while the consensus estimate...
-
Barrington Getting Constructive On Primo Water, Upgrades To Outperform
Tuesday, December 29, 2015 - 10:38am | 273Read More...The share price of Primo Water Corporation (NASDAQ: PRMW) has appreciated 83.76 percent year-to-date, rising almost to its 52-week high on November 9 at $9.40. Michael Petusky of Barrington Research has upgraded the rating on the company from Market Perform to Outperform, with a price target of $9...
-
Opko Health Has Crashed 55% In Three Months; Time To Buy?
Monday, September 28, 2015 - 10:44am | 310Read More...Opko Health Inc. (NYSE: OPK) shares are down 40 percent year-to-date, despite touching a high of $19 on June 2. Barrington Research’s Michael Petusky maintained an Outperform rating on the company, while reducing the price target from $20 to $19. Company specific issues and a weak...
-
Barrington Research Assumes Coverage On Opko Health On Positive Outlook
Thursday, March 26, 2015 - 9:29am | 131Read More...In a report published Thursday, Barrington Research analyst Michael Petusky assumed coverage on Opko Health, Inc. (NYSE: OPK) with an Outperform rating and $19.00 price target. In the report, Barrington Research noted, "We are assuming coverage of OPKO Health due to an analyst transition....
-
Barrington Research Reassumes Coverage DENTSPLY On Limited Upside
Thursday, January 22, 2015 - 12:26pm | 211Read More...Barrington Research reassumed coverage of DENTSPLY International Inc. (NASDAQ: XRAY), after an analyst transition. Michael Petusky and Tareq Affouri are now responsible for coverage and they issued a Market Perform rating. The firm had last rated it at Outperform (May 2014). Although DENTSPLY...
-
Barrington Research Initiates Coverage On Healthways, Cites Strong Macro Environment
Thursday, January 22, 2015 - 11:22am | 170Read More...Michael Petusky of Barrington Research on Thursday initiated coverage of Healthways, Inc. (NASDAQ: HWAY) with an Outperform rating and $25 price target as the company stands to benefit from a strong macro environment. “The estimated addressable market size for the population health...
-
UPDATE: Barrington Research Initiates Coverage On Providence Service
Monday, December 15, 2014 - 5:00pm | 333Read More...Analysts at Barrington Research on Monday initiated coverage of The Providence Service Corporation (NASDAQ: PRSC) by issuing an Outperform rating on the stock and setting a price target of $49. Providence provides home and community-based social service transportation for children...
-
UPDATE: Barrington Research Initiates Coverage On Primo Water
Monday, December 15, 2014 - 2:13pm | 246Read More...Barrington Research initiated coverage on Primo Water Corporation (NASDAQ: PRMW) with an Outperform rating and $6.50 price target. Analyst Michael Petusky noted that “Primo’s water services are currently available in approximately 16,500 retail stores. In addition, there are 7,000...
-
UPDATE: Barrington Research Initiates Coverage On PharMerica
Thursday, November 20, 2014 - 1:02pm | 241Read More...Barrington Research initiated coverage on PharMerica Corporation (NYSE: PMC) Thursday with an Outperform rating and $30 price target. Analysts Michael Petusky and Tareq Affouri noted that the company is well positioned to benefit from several macro-related tailwinds "...including “...
-
UPDATE: Barrington Research Initiates Coverage On BioScrip On Positive Outlook
Thursday, November 20, 2014 - 11:30am | 151Read More...In a report published Thursday, Barrington Research analyst Michael Petusky initiated coverage on BioScrip Inc (NASDAQ: BIOS) with an Outperform rating and $8.00 price target. In the report, Barrington Research noted, “According to the Administration on Aging, by the year 2030 the number of...
-
UPDATE: Barrington Research Assumes Coverage On Haemonetics On Positive Revenue Outlook
Thursday, November 20, 2014 - 11:06am | 107Read More...In a report published Thursday, Barrington Research analyst Michael Petusky assumed coverage on Haemonetics Corporation (NYSE: HAE) with an Outperform rating and $46.00 price target. In the report, Barrington Research noted, “Our price target is $46 and we arrive at our target by attaching a 11x...
